ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Launches Immunology “Dream Team”

December 14, 2012

Trastuzumab Showed Improved Survival In Stage IV Breast Cancer with CNS Metastases

August 26, 2011

NPCC Workshop Developed “Exciting List” Of Projects, Organizer Says

November 8, 1996

Spending Bill Could Give 15% Raise To NIH; Gimmicks Complicate Picture, Veto Looms

November 5, 1999

In Brief: House Appropriations Bill Marked Up, Lid Clamped On; Wells Named DCT Board Chairman

July 6, 1984

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996